EXTINA^® (ketoconazole) Foam, 2% is used on the skin (topical) to treat a skin condition called seborrheic dermatitis in patients 12 years of age and older.

Important Safety Information

The most common side effects of EXTINA^® Foam observed in clinical studies (incidence greater than 1%) included application site burning (10%) and application site reaction (6%).

EXTINA^® Foam may result in contact sensitization, including an allergic reaction that occurs only following sun exposure.

Apply EXTINA^® Foam exactly as prescribed. Talk to your doctor if your skin does not improve after 4 weeks of treatment.

Avoid contact with the eyes and other mucous membranes. EXTINA^® Foam is not for ophthalmic, oral or intravaginal use.

Keep the EXTINA^® Foam can away from and do not spray it near fire, open flame, or direct heat. EXTINA^® Foam is flammable.

Click here for complete Prescribing Information for
EXTINA^® Foam

STIEFEL, STIEFEL & Design, EXTINA, VERSAFOAM, the V Design, VERSAFOAM-HF, VERSAFOAM-HF & Design, STIEFELCARE and STIEFEL CARE & Design are registered trademarks of Stiefel Laboratories, Inc.

You are encouraged to report the side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.